2 December 2013: AccuCore announces AccuPathology version 5.0. Enhancements include support for Soft, CoPath, PowerPath, Millennium, APEasy and others.
Specific features include a new low-cost Specimen Tracking and Verification Module, Natural language LIS search, one-click QA and LIS triggered tasks streamline workflow. The Dashboard includes hover-help with details of discrepancies and gauges for trends. The Peer Review Automation feature incudes automatic capture of gross, whole slide and radiographic images, videos and extramural reports. The Lab Staff Management OPPE/FPPE is enhanced with LIS data mining with exclusions. The Lab Equipment and Reagent feature now has optional Wireless Wi-Fi logging. The Lab Document Management feature includes rules for indicia application and simplified task management with CAP Checklist metadata.
For more information, call (267) 564-5015 or visit www.accucoregroup.com.
2 December 2013: Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announces its CareGiver remote support system to connect Ventana products to the company's support personnel and customers as a way to improve patient care.
The CareGiver remote support system, supported by the Axeda® cloud-based platform solution, is novel in its approach for collecting real-time functionality data from Ventana diagnostic instruments located in pathology customer labs and conveying this data both to customers and Ventana sales and support personnel who can act on the information immediately. This translates into improved efficiency for lab directors and physicians and, most importantly, faster and more reliable results for patients awaiting diagnosis.
For more information, click here.
25 October 2013: Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the global launch of the VENTANA Gram Staining Kit. Automated for use on the VENTANA BenchMark Special Stains instrument, the Gram Staining Kit aids pathologists in the most basic classification of bacteria into Gram-positive and Gram-negative bacteria in fixed tissue samples. Gram stain classification is clinically useful as it provides an initial indication of the nature of a patient's infection.
The Gram stain is part of a family of histochemical special stains that many laboratories around the world still run manually today. In automating the stain, Ventana gives its customers an efficient and automated method to perform this technically challenging assay, enabling them to achieve increased productivity, consistency, and testing quality.
Left: Gram positive and gram negative bacteria with green counterstain, stained using VENTANA Gram Staining Kit on the BenchMark Special Stains automated staining platform
Right: Gram positive and gram negative bacteria with tartrazine counterstain, stained using VENTANA Gram Staining Kit on the BenchMark Special Stains automated staining platform
The Gram Staining kit is the newest addition to the Ventana product offerings on the highly successful, fully automated BenchMark Special Stains platform launched in mid-2012. The kit offers two counterstain options and testing protocol flexibility to meet pathologists' individual preferences.
For more information, click here.
23 October 2013: Zeiss announces its Online Campus with free information about topics ranging from Basic microscopy to advanced techniques. Also included are Interactive Tutorials, Reference Libraries and Review Articles.
16 October 2013: MOPEC introduces the BF100, designed to safely evacuate fumes while filling containers. The drip and spill containment in hinged pan can hold a spill up to 1.6 gallons. Included is a formalin absorbing pad. A nylon strap with push button snaps holds the drip pan in a closed position. The Ventilated Formalin Cube has a Recirculating Filtration System with Pull Out Filter Drawer containing one BF005 - Potassium Permanganate Filter and one BF003 - Particle Filter. An audio and visual alarm alerts personnel of any spills. Using 134 CFM’s the Ventilated Formalin Cube will provide a safer work environment.
BF100 - side view
For more information call 800-362-8491 or email email@example.com or visit www.MOPEC.com.
7 October 2013: Ventana Medical Systems, Inc., a member of the Roche Group, announces the global launch of the industry's first BRAF V600E immunohistochemistry test to detect the BRAF V600E mutation in a variety of tumors. V600E, the most frequent BRAF mutation, plays a key role in a variety of cancers including colorectal cancer–the third most common type of cancer and third leading cause of cancer deaths worldwide. The BRAF V600E mutation also plays a role in melanoma, papillary thyroid cancer and hairy cell leukemia.
Colorectal carcinoma is BRAF V600E+ with OptiView DAB IHC detection
The Ventana BRAF V600E (VE1) Mouse Monoclonal Primary Antibody IHC assay is the result of the company's exclusive license agreement with the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the University Hospital Heidelberg, Germany. The assay is optimized to perform on all VENTANA Benchmark IHC platforms with the OptiView DAB IHC Detection Kit.
Roche also offers the Cobas® 4800 BRAF V600 Mutation Test, which is the companion diagnostic for Zelboraf® (vemurafenib). This test was clinically validated to select patients in the pivotal BRIM-3 study, and only patients selected by this test were shown to benefit from Zelboraf therapy.
For more information, click here.
30 September 2013: Spring Bioscience, Inc. announces a new addition to its specialized portfolio of valuable antibodies for cancer research with the introduction of the Anti-PTEN (SP218) rabbit monoclonal immunohistochemistry (IHC) antibody.
PTEN is a common protein found in most tissues of the body. The protein acts as part of a critical cell signaling pathway that tells cells to stop dividing, helping to prevent uncontrolled cell growth that can lead to the formation of tumors. Mutations in the PTEN gene, together with other factors resulting in loss of PTEN protein, are a step in the development of many human cancers, including prostate and colon cancer. PTEN mutations are also believed to be the cause of a variety of inherited predispositions to cancer.
Spring internal comparison studies demonstrated that SP218 provides more accurate, sensitive, and specific detection compared to similar research use only (RUO) tests on the market today.
For more information, click here.
17 September 2013: Ventana Medical Systems, Inc., a member of the Roche Group, announces that it has entered into an agreement with data storage and IT infrastructure industry leader EMC Corporation (EMC) to offer a highly scalable and flexible solution to store and archive medical images as part of the VENTANA digital pathology solution for anatomical pathology labs.
Today's pathologists increasingly rely on digital images scanned from patient slides, and those images must be of the highest possible resolution. The VENTANA iScan family of slide scanners offers enhanced image resolution and throughput, which in turn requires significant increases in system storage capacity. Ventana turned to IT industry leader EMC to deliver secure, easy to manage, high-capacity storage for its digital pathology solution which runs on VENTANA Virtuoso image and workflow management software.
For more information, click here.
26 August 2013: PerkinElmer and Advanced Cell Diagnostics (ACD) have entered a co-marketing agreement to develop joint applications for the visualization of multiplexed fluorescence RNA biomarkers in situ, in formalin-fixed paraffin-embedded tissues. In the past, it was not possible to detect and quantify RNA in situ in these samples due to lack of sensitivity and specificity of labels within highly autofluorescent tissues.
Click here for more information.
21 August 2013: Aperio ePathology, a leader in providing global pathology solutions, has digitized over 550 slides of Einstein’s brain enabling researchers, scientists and enthusiasts around the world to view the original slides prepared by Dr. Thomas Harvey, the pathologist who conducted the autopsy of Albert Einstein in 1955. The remarkable collection of slides was donated to the National Museum of Health and Medicine in Silver Spring, MD after the pathologist's death. The Einstein Brain Atlas app for iPad has been developed to allow neuroscientists, researchers, educators and others interested in science to explore sections of the Nobel Prize-winning physicist’s brain in microscopic detail. For more information, click here.
3 July 2013: Milestone introduces the BoneSTATION, a dedicated system for standardization of fixation and decalcification of bone specimens. Optimize molecular testing results with increased RNA yield from routine cases by combining less aggressive decalcifying solutions with the BoneSTATION's controlled agitation and temperature management. Users can access and build time-saving protocols through a touch screen icon driven interface, which also enables temperature control and monitoring.
Space restricted laboratories will appreciate the BoneSTATION's small footprint. Two work platforms, one for decalcification, contains a stirring heating plate paired with an infrared sensor for precise temperature control. The second platform contains the fixation area, which maintains homogeneous reagent temperatures with an integrated magnetic stirrer. Also, an included glass "workbench" provides users with an area to assess specimen quality.
For more information, call 866-995-5300, email firstname.lastname@example.org
or visit www.milestonemed.com.
12 June 2013: HANSEL Stain has been the recommended in-vitro diagnostic stain for the identification of eosinophils in secretions for many years. Please see our product summary on Pathology Outlines here.
Lide Laboratories also offers other diagnostics stains including our new Urine Sediment Stain and Tinea Test Stain. Our concentrated Urine Sediment Stain combines Crystal Violet (0.1%), Ammonium Oxalate (0.03%) and Safranin O (0.25%) with the base formula used in HANSEL Stain. Our Tinea Test Stain [Lactophenol Cotton (Aniline) Blue (0.05%)] is formulated for the microscopic examination of fungi.
Please see our web page for more information: www.lidelabs.com/diagnosticstains.html. New customers can send us a request for free samples on our Contact Us web page.
14 April 2013: PSA is pleased to announce that we are now part of McKesson. This combined organization brings together an extensive portfolio of services and we are now better positioned to help our customers choose from a broader set of services from practice and revenue cycle management to coding, marketing and networking capabilities.
To learn more, visit www.PSApath.com, or contact Leigh Polk at email@example.com.
13 October 2012: Introducing EXAKT’s NEW Pathology Saw. Designed specifically for pathology lab use, this bone saw offers the SAFEST alternative for grossing samples. Unlike butcher saws used in many labs, the diamond band of the EXAKT saw does not cut, but grinds the bone very precisely. There is no immediate risk of injury to the technician if the band is touched unintentionally. The EXAKT 312 Diamond Pathology Saw easily cuts metal implants or screws encountered during the grossing process, without destroying the sample. Even very small specimens can be cut safely and precisely! Visit www.exaktusa.com/pathology-saw and watch the EXAKT Pathology Saw Video.
11 November 2011: bioTheranostics, Inc., a bioMérieux company that develops innovative oncology diagnostic tests to drive personalized treatment, announces a clinical study that links CancerTYPE ID® molecular testing with improved patient outcome. Patients in which CancerTYPE ID predicted a colorectal site of origin that subsequently received site-specific therapy had a median survival three times that of what has been reported in patients treated empirically for cancer of unknown primary (CUP). These results make CancerTYPE ID the only marketed molecular cancer classifier to demonstrate therapeutic response and patient benefit based on molecular tumor profiling.
The study, led by John Hainsworth, MD, of the Sarah Canon Research Institute, A Retrospective Study of Treatment Outcomes in Patients with Carcinoma of Unknown Primary Site and a Colorectal Cancer Molecular Profile (Clin Colorectal Cancer 2011 Oct 13 [Epub ahead of print]), focused on the improved treatment response and survival in a group of patients in which CancerTYPE ID results were utilized in the selection of site-specific therapy. According to the study findings, which will be published in the December issue of Clinical Colorectal Cancer and currently are available online, 75 percent of the patients showed negative colonoscopy results, and approximately half the patients had atypical immunohistochemistry for colorectal cancer. Significantly, CancerTYPE ID was used as part of the routine work-up and site-specific treatment was selected based on the molecular assay prediction.
The study results demonstrated a 50 percent response rate in patients treated with first-line regimens for colorectal cancer versus only 17 percent in patients treated with current empiric therapies for CUP (P value = 0.0257). Patients predicted to have colorectal cancer by CancerTYPE ID and treated with colorectal cancer treatment regimens experienced a median survival of 27 months. In comparison, patients treated with empiric CUP treatment have historical median survivals ranging from 8 to 11 months.
For more information please contact Wendy Johnson, Associate Director Marketing, bioTheranostics, 858-587-5887 or click here.
26 July 2011: OPTRONICS® presents a case study about High Definition Hematology. In 2009, the Royal Berkshire Hospital (RBH) made the decision to update its microscope camera system. Located in the Haematology Department, the equipment originally consisted of a microscope mounted analogue video camera connected to a 21-inch professional monitor. This was used for presentations and training purposes for over ten years until it started to fail and display picture defects. Click here to read the short article.
For more information, contact Rich Crandall, Director of Business Development at 805.562.3980 or firstname.lastname@example.org, or visit us online at http://www.optronics.com.
29 April 2011: An article in the January 2011 CAP Today discussed Voicebrook’s leadership in the Pathology speech recognition arena. The article focuses on the role of speech recognition software for laboratory transcription, and indicates that Voicebrook’s VoiceOver software is the only speech recognition product that is designed for pathologists. Features important for Pathologists include advanced templating, discrete data entry and CAP Cancer protocols, a knowledge base of Pathology templates, hands-free microphone and foot pedal integration, delegated and digital dictation workflows, custom integration with over 16 AP/LIS products, downtime procedures, integration with Digital Imaging platforms, and customized vocabulary and functionality to handle unique Pathology reporting workflows.
For more information, please visit http://www.voicebrook.com or click here to read the article.
26 January 2011: ARUP’s Online Scientific Resource for Research and Education provides more than 20 free CME courses for physicians. Course topics reflect current issues and developments in pathology; new courses are added monthly. This resource is provided by ARUP’s medical directors, who are faculty at the University of Utah School of Medicine, along with other highly qualified expert contributors.
The University of Utah School of Medicine designates these educational activities for AMA PRA Category 1 credit(s) and affirms that they meet the criteria for Self-Assessment Modules (SAM) credit to apply toward the Maintenance of Certification (MOC) by the American Board of Pathology.
For more information, click here.
18 June 2009: Photodyne Technologies is a manufacturer of specialized photographic machines for use in grossing, pathology and forensic labs, and other macro photography applications. Our new macro-photography and grossing units have an optional low voltage D.C. operation, for enhanced safety. The units are supplied with top of the line digital cameras, with resolution of 8 to 15 megapixels and higher. The system comes with proprietary software and connects directly to the user’s computer through a USB port, allowing the user to take pictures directly from the computer in real time, with adjustments in the scene as necessary. All major attributes of the camera are controllable from the computer as well.
Once the picture is snapped, the data are transferred to the hard drive through the USB port and stored in the user’s specified location, and the pictures are then ready to be used for lectures and presentations, archiving, email attachments, research and more.
Visit us online at www.photodyne.com or contact us at 800-660-2147 or email@example.com for more information.
10 February 2009: Vachette Pathology is proud to announce its newly improved website Vachettepathology.com. The website will have more content and more information. The goal of the website will be to concentrate all the knowledge and experience we have into a single database that is more useable for both our current and potential customers.
Vachette Pathology is a practice management firm that specializes in pathology. Currently we work with over 450 pathologists nationwide and are commonly held as the industry leaders in the business of pathology and laboratory management.
If you have any questions or for further information, please contact Mick Raich toll free at 866-407-0763, or email firstname.lastname@example.org
10 September 2008: Sakura announces The Tissue-Tek® Xpress® x50. The Tissue-Tek® Xpress® x50 delivers unprecedented productivity and maximizes staff efficiency. The Tissue-Tek® Xpress® x50 processes up to 440 specimens in an 8-hour shift, with the ability to load up to 40 cassettes approximately every 45 minutes. It provides outstanding time and cost savings, as well as increased staff safety, while producing standardized, accurate results paralleling those from overnight processing, allowing same-day diagnosis and, ultimately, improved patient care.
For more information, visit us online (click here), write to email@example.com, or call 1-800-725-8723 and press 1 for customer service.